ES2154788T3 - Procedimiento para la preparacion de 1-(2'-desoxi-2',2'-difluoro-d-ribo-pentofuranosil)-citosina a partir de 2-desoxi-2,2-difluoro-beta-d-ribo-pentopiranosa. - Google Patents

Procedimiento para la preparacion de 1-(2'-desoxi-2',2'-difluoro-d-ribo-pentofuranosil)-citosina a partir de 2-desoxi-2,2-difluoro-beta-d-ribo-pentopiranosa.

Info

Publication number
ES2154788T3
ES2154788T3 ES96300419T ES96300419T ES2154788T3 ES 2154788 T3 ES2154788 T3 ES 2154788T3 ES 96300419 T ES96300419 T ES 96300419T ES 96300419 T ES96300419 T ES 96300419T ES 2154788 T3 ES2154788 T3 ES 2154788T3
Authority
ES
Spain
Prior art keywords
ribo
difluoro
desoxi
cytosine
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96300419T
Other languages
English (en)
Inventor
David D Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2154788T3 publication Critical patent/ES2154788T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN PROCEDIMIENTO PARA LA PREPARACION DE 1-(2''DEOXI-2'',2''-DIFLUORO-D-RIBO-PENTOFURANOSIL)-CITOSINA (VI) A PARTIR DE 2-DEOXI-2,2-DIFLUORO-{BE}-D-RIBO-PENTOPIRANOSA (I). EL PROCEDIMIENTO UTILIZA UNA REACCION DE TRITILACION (PASO 3) PARA LA PREPARACION DE 2-DEOXI-2,2-DIFLUORO-5-O-TRIFENILMETIL-RIBOPENTOFURANOSA (II) COMO INTERMEDIARIO CLAVE. LA 1-(2''-DEOXI2'',2''-DIFLUORO-D-RIBO-PENTOFURANOSIL)-CITOSINA (VI) ES UN AGENTE ANTIVIRAL Y ANTICANCERIGENO.
ES96300419T 1995-02-03 1996-01-22 Procedimiento para la preparacion de 1-(2'-desoxi-2',2'-difluoro-d-ribo-pentofuranosil)-citosina a partir de 2-desoxi-2,2-difluoro-beta-d-ribo-pentopiranosa. Expired - Lifetime ES2154788T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/383,165 US5559222A (en) 1995-02-03 1995-02-03 Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose

Publications (1)

Publication Number Publication Date
ES2154788T3 true ES2154788T3 (es) 2001-04-16

Family

ID=23511995

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96300419T Expired - Lifetime ES2154788T3 (es) 1995-02-03 1996-01-22 Procedimiento para la preparacion de 1-(2'-desoxi-2',2'-difluoro-d-ribo-pentofuranosil)-citosina a partir de 2-desoxi-2,2-difluoro-beta-d-ribo-pentopiranosa.

Country Status (10)

Country Link
US (2) US5559222A (es)
EP (1) EP0727433B1 (es)
JP (1) JPH08245685A (es)
AT (1) ATE199724T1 (es)
CA (1) CA2168080C (es)
DE (1) DE69612024T2 (es)
DK (1) DK0727433T3 (es)
ES (1) ES2154788T3 (es)
GR (1) GR3035931T3 (es)
PT (1) PT727433E (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
CN1438981A (zh) * 2000-04-21 2003-08-27 罗迪亚/奇莱克斯公司 制备r－1－(芳氧基)丙－2－醇的方法
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
JP2008531680A (ja) * 2005-03-04 2008-08-14 ダブール・ファーマ・リミテッド βアノマーが富化された２１−デオキシ−２１，２１−ジフルオロ−Ｄ−リボフラノシルヌクレオシドの調製のための中間体と方法
CA2610283C (en) * 2005-06-03 2011-08-30 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
AU2011202539B2 (en) * 2005-06-03 2012-07-05 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
JP2009526782A (ja) * 2006-02-07 2009-07-23 ケマジス・リミテッド ゲムシタビンおよび関連中間体の製造方法
US20070249823A1 (en) * 2006-04-20 2007-10-25 Chemagis Ltd. Process for preparing gemcitabine and associated intermediates
CN101024667B (zh) * 2007-03-30 2011-01-26 湖北益泰药业有限公司 盐酸吉西他宾的合成方法
US20080262215A1 (en) * 2007-04-23 2008-10-23 Chemagis Ltd. Gemcitabine production process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
CA1324128C (en) * 1987-08-28 1993-11-09 Ta-Sen Chou 2', 2'-difluoronucleosides
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4954623A (en) * 1989-03-20 1990-09-04 Eli Lilly And Company Recovery of difluoro sugar
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5426183A (en) * 1992-06-22 1995-06-20 Eli Lilly And Company Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів

Also Published As

Publication number Publication date
DE69612024T2 (de) 2001-09-06
CA2168080C (en) 2007-05-29
US5608043A (en) 1997-03-04
PT727433E (pt) 2001-06-29
EP0727433A1 (en) 1996-08-21
EP0727433B1 (en) 2001-03-14
JPH08245685A (ja) 1996-09-24
GR3035931T3 (en) 2001-08-31
DK0727433T3 (da) 2001-04-17
DE69612024D1 (de) 2001-04-19
US5559222A (en) 1996-09-24
ATE199724T1 (de) 2001-03-15
CA2168080A1 (en) 1996-08-04

Similar Documents

Publication Publication Date Title
ES2195970T3 (es) L-ribavirina y usos de la misma.
CA2167361A1 (en) 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
IT1298126B1 (it) Procedimento per la preparazione di epossidi olefinici
ES2154788T3 (es) Procedimiento para la preparacion de 1-(2'-desoxi-2',2'-difluoro-d-ribo-pentofuranosil)-citosina a partir de 2-desoxi-2,2-difluoro-beta-d-ribo-pentopiranosa.
PT94226A (pt) Processo de preparacao de 1,2-dioxetanos que produzem quimioluminescencia por activacao dupla
ES2122905A1 (es) Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
DE69408099D1 (de) 5-Methyluridin-Verfahren zur Herstellung von 2',3'-didehydro-3'-desoxythymidin (d4T) im Grossmassstab
ES2138212T3 (es) Derivado de la vitamina d3 y procedimiento para producirlo.
WO1997014712A3 (de) Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
PT92307A (pt) Processo para a preparacao de derivados de 3,5-dimetil-4-metoxipiridina e de produtos intermediarios
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
ATE18054T1 (de) Derivate und reduktionsprodukte der dglucopyranosyl-alpha(1-5)-d-arabonsaeure, deren herstellung und verwendung.
EP0714900A3 (de) Alkylhydrogenchlorsilane, Verfahren zu deren Herstellung und deren Verwendung
NO148109C (no) Fremgangsmaate ved fremstilling av 5`deoksy-5-fluoridin.
ES2097103T1 (es) Metodo de producir almidon cationico.
NO911490D0 (no) Fremgangsmaate for hydrogenperoksydbleking av papirmasse, med hoeyt utbytte.
KR890008160A (ko) 약학적 뉴클레오시드
NO891835D0 (no) Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider.
BRPI9607850B8 (pt) compostos intermediários para síntese de nucleosídeos.
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.
ES2168586T3 (es) Un procedimiento para la preparacion de 2'-desoxi-2'-halocoformicinas o estereoisomeros de las mismas.
ATE176242T1 (de) Uck14-verbindungen
ES2038209T3 (es) Procedimiento para la obtencion de 1-aminoantraquinonas.
IT8919959A0 (it) Nuovo processo per la sintesi della n metil 3,4 dimetossifeniletilamina.
ES2163023T3 (es) Derivados del 2-azabiciclo(2.2.1)heptano, su preparacion y su aplicacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 727433

Country of ref document: ES